Home / Companies / News / Domestic branded generic formulations market can grow at 10-12%: Industry

Domestic branded generic formulations market can grow at 10-12%: Industry

Cadila Healthcare Chairman Pankaj Patel said the market can grow when there is overall growth

A large drug firm has 12-15 therapy divisions, and if each launches a few drugs, the company brings to the market 30-50 brands a year.

Premium

Dilip Shanghvi, managing director of Sun Pharmaeuticals, said the industry growth will be few percentage points more than the GDP growth

BS Reporter

1 min read Last Updated : Apr 15 2022 | 12:51 AM IST

The pharma industry captains feel the domestic branded generic formulations market can grow at 10-12 per cent annually for the next few years.

Speaking at a conference, Cadila Healthcare Chairman Pankaj Patel said the market can grow when there is overall growth, and the GDP grows, because most of the spend is still out of the pocket. He feels that the market can clock 10-12 per cent growth over the next few years.

Dilip Shanghvi, managing director of Sun Pharmaeuticals, said the industry growth will be few percentage points more than the GDP growth. As life expectancy increases, the sales of the

Topics : Pharma sector pharma market

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in